Metformin

A stroke of luck

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Metformin is an oral glucose-lowering drug that has been widely used for more than half a century. Both the American Diabetes Association and the European Association for the study of Diabetes recommend metformin as the first line therapy for the treatment of type II diabetes mellitus. Metformin has considerably evolved from being an antidiabetic into a drug with a wider potential of therapeutic uses such as anticancer, antiaging, treatment of gestational hypertension, preeclampsia and weight loss. In addition to the in-label use of metformin as an anti-hyperglycemic medication, it is widely prescribed as an off label therapy for young women with Poly Cystic Ovary Syndrome for the treatment of symptoms associated with the disorder. This article is a brief summary that lists and briefly discusses current and potential non-hyperglycemic uses and effects of metformin.

Original languageEnglish
Article numberem143
JournalElectronic Journal of General Medicine
Volume16
Issue number3
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Metformin
Stroke
Therapeutics
Pregnancy Induced Hypertension
Therapeutic Uses
Pre-Eclampsia
Hypoglycemic Agents
Pharmaceutical Preparations
Type 2 Diabetes Mellitus
Weight Loss
Ovary
Glucose

Keywords

  • Cancer
  • Cardiovascular
  • Mechanism of action
  • Metformin
  • PCOS

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Metformin : A stroke of luck. / Aljofan, Mohamad; Gaipov, Abduzhappar.

In: Electronic Journal of General Medicine, Vol. 16, No. 3, em143, 01.01.2019.

Research output: Contribution to journalReview article

@article{e544a410ee8e4c34b1189053f59f93e0,
title = "Metformin: A stroke of luck",
abstract = "Metformin is an oral glucose-lowering drug that has been widely used for more than half a century. Both the American Diabetes Association and the European Association for the study of Diabetes recommend metformin as the first line therapy for the treatment of type II diabetes mellitus. Metformin has considerably evolved from being an antidiabetic into a drug with a wider potential of therapeutic uses such as anticancer, antiaging, treatment of gestational hypertension, preeclampsia and weight loss. In addition to the in-label use of metformin as an anti-hyperglycemic medication, it is widely prescribed as an off label therapy for young women with Poly Cystic Ovary Syndrome for the treatment of symptoms associated with the disorder. This article is a brief summary that lists and briefly discusses current and potential non-hyperglycemic uses and effects of metformin.",
keywords = "Cancer, Cardiovascular, Mechanism of action, Metformin, PCOS",
author = "Mohamad Aljofan and Abduzhappar Gaipov",
year = "2019",
month = "1",
day = "1",
doi = "10.29333/ejgm/108679",
language = "English",
volume = "16",
journal = "Electronic Journal of General Medicine",
issn = "1304-3889",
publisher = "Modestum Ltd.",
number = "3",

}

TY - JOUR

T1 - Metformin

T2 - A stroke of luck

AU - Aljofan, Mohamad

AU - Gaipov, Abduzhappar

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Metformin is an oral glucose-lowering drug that has been widely used for more than half a century. Both the American Diabetes Association and the European Association for the study of Diabetes recommend metformin as the first line therapy for the treatment of type II diabetes mellitus. Metformin has considerably evolved from being an antidiabetic into a drug with a wider potential of therapeutic uses such as anticancer, antiaging, treatment of gestational hypertension, preeclampsia and weight loss. In addition to the in-label use of metformin as an anti-hyperglycemic medication, it is widely prescribed as an off label therapy for young women with Poly Cystic Ovary Syndrome for the treatment of symptoms associated with the disorder. This article is a brief summary that lists and briefly discusses current and potential non-hyperglycemic uses and effects of metformin.

AB - Metformin is an oral glucose-lowering drug that has been widely used for more than half a century. Both the American Diabetes Association and the European Association for the study of Diabetes recommend metformin as the first line therapy for the treatment of type II diabetes mellitus. Metformin has considerably evolved from being an antidiabetic into a drug with a wider potential of therapeutic uses such as anticancer, antiaging, treatment of gestational hypertension, preeclampsia and weight loss. In addition to the in-label use of metformin as an anti-hyperglycemic medication, it is widely prescribed as an off label therapy for young women with Poly Cystic Ovary Syndrome for the treatment of symptoms associated with the disorder. This article is a brief summary that lists and briefly discusses current and potential non-hyperglycemic uses and effects of metformin.

KW - Cancer

KW - Cardiovascular

KW - Mechanism of action

KW - Metformin

KW - PCOS

UR - http://www.scopus.com/inward/record.url?scp=85067181115&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067181115&partnerID=8YFLogxK

U2 - 10.29333/ejgm/108679

DO - 10.29333/ejgm/108679

M3 - Review article

VL - 16

JO - Electronic Journal of General Medicine

JF - Electronic Journal of General Medicine

SN - 1304-3889

IS - 3

M1 - em143

ER -